Last month, the Pharmaceutical Research and Manufacturers of America (PhRMA) published a report entitled “The U.S. Biopharma Industry: Perspectives on Future Growth and the Factors That Will Drive It,”  examining U.S. biopharma’s future. Developed by Battelle’s Technology Partnership practice, and based on research as well as the results of an executive survey, the report concludes that the U.S. could lose 140,000 jobs in biopharmaceutical research and manufacturing and the areas that depend on ...